Published online Jan 16, 2014. doi: 10.4253/wjge.v6.i1.13
Revised: November 11, 2013
Accepted: December 9, 2013
Published online: January 16, 2014
Core tip: Radiofrequency ablation (RFA) is a promising tool for the treatment of patients with perihilar and intrahepatic bile duct cancer. While RFA is easy to perform and technical success rates are high, the outcome of patients remains unclear. Therefore, the long-term efficacy of this treatment approach needs to be studied in randomized trials.